Savant Capital LLC acquired a new position in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 8,622 shares of the financial services provider’s stock, valued at approximately $1,599,000.
Other institutional investors also recently modified their holdings of the company. Numerai GP LLC increased its position in shares of Marsh & McLennan Companies by 966.2% in the third quarter. Numerai GP LLC now owns 37,220 shares of the financial services provider’s stock worth $7,501,000 after purchasing an additional 33,729 shares during the last quarter. Swiss Life Asset Management Ltd increased its position in shares of Marsh & McLennan Companies by 9.5% in the fourth quarter. Swiss Life Asset Management Ltd now owns 134,542 shares of the financial services provider’s stock worth $24,960,000 after purchasing an additional 11,648 shares during the last quarter. Rockland Trust Co. increased its position in shares of Marsh & McLennan Companies by 801.6% in the third quarter. Rockland Trust Co. now owns 12,073 shares of the financial services provider’s stock worth $2,433,000 after purchasing an additional 10,734 shares during the last quarter. Barclays PLC increased its position in shares of Marsh & McLennan Companies by 41.7% in the third quarter. Barclays PLC now owns 2,202,372 shares of the financial services provider’s stock worth $443,844,000 after purchasing an additional 647,987 shares during the last quarter. Finally, Bridges Investment Management Inc. increased its position in shares of Marsh & McLennan Companies by 4.4% in the third quarter. Bridges Investment Management Inc. now owns 76,196 shares of the financial services provider’s stock worth $15,356,000 after purchasing an additional 3,177 shares during the last quarter. 87.99% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
Several analysts have issued reports on the company. Keefe, Bruyette & Woods upped their target price on Marsh & McLennan Companies from $200.00 to $203.00 and gave the stock a “market perform” rating in a research note on Friday, April 17th. Barclays cut their target price on Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating for the company in a research note on Wednesday, April 8th. JPMorgan Chase & Co. cut their target price on Marsh & McLennan Companies from $226.00 to $206.00 and set an “overweight” rating for the company in a research note on Thursday, April 9th. Cantor Fitzgerald upped their target price on Marsh & McLennan Companies from $208.00 to $212.00 and gave the stock an “overweight” rating in a research note on Monday, February 2nd. Finally, Bank of America cut their target price on Marsh & McLennan Companies from $181.00 to $174.00 and set an “underperform” rating for the company in a research note on Tuesday, April 14th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, ten have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $203.56.
Insider Buying and Selling at Marsh & McLennan Companies
In other news, CEO John Q. Doyle sold 16,655 shares of the firm’s stock in a transaction on Wednesday, March 4th. The stock was sold at an average price of $183.30, for a total transaction of $3,052,861.50. Following the completion of the transaction, the chief executive officer directly owned 116,811 shares in the company, valued at $21,411,456.30. This trade represents a 12.48% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.38% of the stock is owned by insiders.
Marsh & McLennan Companies Stock Performance
NYSE:MRSH opened at $159.73 on Monday. The company has a debt-to-equity ratio of 1.28, a quick ratio of 1.11 and a current ratio of 1.11. The company’s 50 day moving average is $164.87. The stock has a market capitalization of $77.17 billion, a price-to-earnings ratio of 19.97, a PEG ratio of 2.33 and a beta of 0.62. Marsh & McLennan Companies, Inc. has a fifty-two week low of $157.74 and a fifty-two week high of $235.78.
Marsh & McLennan Companies (NYSE:MRSH – Get Free Report) last issued its quarterly earnings data on Thursday, April 16th. The financial services provider reported $3.29 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.21 by $0.08. Marsh & McLennan Companies had a net margin of 14.26% and a return on equity of 31.87%. The business had revenue of $7.30 billion for the quarter. Marsh & McLennan Companies’s quarterly revenue was up 7.6% on a year-over-year basis. Research analysts predict that Marsh & McLennan Companies, Inc. will post 10.38 EPS for the current year.
Marsh & McLennan Companies Company Profile
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Recommended Stories
- Five stocks we like better than Marsh & McLennan Companies
- These 3 CLO ETFs Target a Niche Corner of the Fixed-Income Market
- 3 Ways to Play the Data Center Land Grab
- The Smarter Way to Invest in AI Without Taking Extreme Risk
- 3 Dividend Kings That Earn Their Crown Every Quarter
Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report).
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
